Rising T J, Fromson J M, McEwen J, Johnson P
Arzneimittelforschung. 1977;27(4):872-8.
Tritiated 2-ethoxy-6,9-diaminoacridine (ethacridine lactate, Rivanol) has been orally administered to rat, dog, rabbit and man, and the distribution of radioactivity between urine and faeces determined. Complete recoveries of radioactivity were obtained from rat, rabbit and man. From direct measurement of levels of radioactivity, the maximum percentage of the dose excreted via the urine varied from 1.7% (man) to 6.1% (dog). Tritiated water accounted for nearly 50% of this amount. The low levels of radioactivity in plasma of dog and man and in the bile of rats following administration of 3H-ethacridine lactate suggested that there was only a low degree of oral absorption and substantiated previous reports that the drug is essentially unabsorbed in man. From fluorimetric measurements and the determination of levels of radioactivity in ether extracts of urine, it could be concluded that for all species less than 0.1% of the dose appeared in the urine as acridine-like material.
将氚标记的2-乙氧基-6,9-二氨基吖啶(乳酸依沙吖啶,利凡诺)经口给予大鼠、狗、兔子和人类,并测定尿液和粪便中放射性的分布。在大鼠、兔子和人类中均实现了放射性的完全回收。通过直接测量放射性水平,经尿液排泄的剂量的最大百分比在1.7%(人类)至6.1%(狗)之间变化。氚水占该量的近50%。给予3H-乳酸依沙吖啶后,狗和人类血浆以及大鼠胆汁中的放射性水平较低,这表明口服吸收程度较低,并证实了先前关于该药物在人类中基本不被吸收的报道。通过荧光测量以及测定尿液乙醚提取物中的放射性水平,可以得出结论,对于所有物种,尿液中以吖啶样物质形式出现的剂量不到0.1%。